170 related articles for article (PubMed ID: 28836148)
1. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes.
Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA
Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148
[TBL] [Abstract][Full Text] [Related]
2. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
[TBL] [Abstract][Full Text] [Related]
3. Esculentin-2CHa(1-30) and its analogues: stability and mechanisms of insulinotropic action.
Vasu S; McGahon MK; Moffett RC; Curtis TM; Conlon JM; Abdel-Wahab YH; Flatt PR
J Endocrinol; 2017 Mar; 232(3):423-435. PubMed ID: 28115493
[TBL] [Abstract][Full Text] [Related]
4. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
[TBL] [Abstract][Full Text] [Related]
5. Insulinotropic, glucose-lowering, and beta-cell anti-apoptotic actions of peptides related to esculentin-1a(1-21).NH
Musale V; Abdel-Wahab YHA; Flatt PR; Conlon JM; Mangoni ML
Amino Acids; 2018 Jun; 50(6):723-734. PubMed ID: 29549522
[TBL] [Abstract][Full Text] [Related]
6. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
[TBL] [Abstract][Full Text] [Related]
7. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
[TBL] [Abstract][Full Text] [Related]
8. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
[TBL] [Abstract][Full Text] [Related]
9. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance.
Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):769-81. PubMed ID: 27068334
[TBL] [Abstract][Full Text] [Related]
10. Beneficial actions of esculentin-2CHa(GA30) on high sucrose-induced oxidative stress in Drosophila melanogaster.
Adesanoye OA; Farodoye OM; Adedara AO; Falobi AA; Abolaji AO; Ojo OO
Food Chem Toxicol; 2021 Nov; 157():112620. PubMed ID: 34656695
[TBL] [Abstract][Full Text] [Related]
11. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy.
Conlon JM; Mechkarska M; Abdel-Wahab YH; Flatt PR
Peptides; 2018 Feb; 100():275-281. PubMed ID: 28887047
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.
Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
Amino Acids; 2016 Feb; 48(2):535-47. PubMed ID: 26439377
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice.
O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
PLoS One; 2018; 13(8):e0202350. PubMed ID: 30157220
[TBL] [Abstract][Full Text] [Related]
14. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
Irwin N; Pathak V; Pathak NM; Gault VA; Flatt PR
Diabetes Obes Metab; 2015 Sep; 17(9):887-95. PubMed ID: 26095087
[TBL] [Abstract][Full Text] [Related]
15. Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat diet.
Abdel-Wahab YH; Patterson S; Flatt PR; Conlon JM
Horm Metab Res; 2010 Aug; 42(9):652-6. PubMed ID: 20496306
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
[TBL] [Abstract][Full Text] [Related]
17. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
[TBL] [Abstract][Full Text] [Related]
18. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
[TBL] [Abstract][Full Text] [Related]
19. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324
[TBL] [Abstract][Full Text] [Related]
20. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
Irwin N; Pathak V; Flatt PR
Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
